WebJCOG0603: Are We Really Sure This Was a Negative Trial? J Clin Oncol. 2024 Jan 13;JCO2102299. doi: 10.1200/JCO.21.02299. Online ahead of print. Authors Rita Saude Conde 1 , Giacomo Bregni 1 , Everardo Saad 1 , Alain Hendlisz 1 , Francesco Sclafani 1 Affiliation 1 Rita Saude Conde, MD, Institut Jules Bordet ... Web11 nov 2024 · In recently published findings from the phase 2/3 JCOG0603 trial (UMIN000000653), investigators recruited patients aged 20 to 75 years with confirmed CRC and an unlimited number of liver ...
A randomized phase II/III trial comparing hepatectomy followed …
Web结直肠癌发病率呈逐年上升趋势,肝脏是其远处转移最常见的靶器官。目前传统影像学在发现结直肠癌隐匿性肝转移灶、预测异时性肝转移及评估治疗反应方面仍有不足。影像组学可从医学图像数据中挖掘并提取肉眼难以分辨的信息,反映肿瘤内部异质性特征,从而为结直肠癌肝转移的预测、诊断、疗效 ... Web2024年、米国臨床腫瘍学会においてjcog0603試験の結果が発表されました。今回はエキスパートの先生方にお集まりいただき、試験から独立した立場で結果をどう解釈しているか、実地診療に与える影響をどう考えておられるかについてご意見をお伺いしたいと思います。 alex baird double glazing
第5回座談会 大腸がん肝転移症例の術後補助化学療法について
Web13 gen 2024 · JCOG0603: Are We Really Sure This Was a Negative Trial? The following represents disclosure information provided by authors of this manuscript. All … Web1 apr 2024 · Purpose: It remains controversial whether primary tumor resection (PTR) before chemotherapy improves survival in patients with colorectal cancer (CRC) with asymptomatic primary tumor and synchronous unresectable metastases. Patients and methods: This randomized phase III study investigated the superiority of PTR followed by … Web2 dic 2024 · Disease-free survival (DFS) is also a promising candidate for primary endpoint, but as in JCOG0603, special attention must be paid when DFS does not correlate with OS. Although careful discussion is required because the precision of the hazard ratio depends on the number of events, an alternative population-level summary of variables, including … alex bazzaro twitter